Company intelligence / Profile preview

Meda

Solna, Swedenmeda.se ↗
Ownership
Public · MEDA
Employees
~5200
Development stage
Commercial
01

Overview

Meda was a leading international specialty pharmaceutical company with a broad commercial portfolio in allergy/respiratory care, CNS disorders, women’s health/gastroenterology/pain management. Its marketed products included prescription drugs such as Astelin nasal spray for allergies and Onsolis for cancer pain. The company expanded through acquisitions of brands/products/divisions in Europe and the US. It was acquired by Mylan in a €7.2 billion deal in August/September of 2016.

Therapeutic areas
GastroenterologyPulmonologyRheumatologyImmunologyEndocrinologyOtherWomen's HealthOncologyNeurology
Modalities
Small moleculeBiologicCombination drugsTransdermal drug delivery systemsNasal spraysInhaled therapies
Industry
Biotech
02

Partnerships

Wyeth/Pfizer (product acquisitions)various distribution partners globally
03

Financials

Market cap
$13.3M
Total revenue
$219.6M
Enterprise value
$66.8M

Beyond the preview

Go deeper on Meda.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meda.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call